Catalyst Pharmaceuticals, Inc. CPRX

Set alert

Price alert · CPRX

All alert types
31.49 USD 0.00 0.00%

As of Jul 15, 9:30 AM ET

Bid
31.48 × 1
Ask
31.49 × 1
31.49 Day range 31.49
20.66 52-week range 32.56
YTD
+34.92%
1 year
+43.86%
Open
31.49
Prev close
31.49
Mkt cap
3.85B
Vol
0
Avg vol
2.62M
EPS
1.74
P/E
17.49
Div yield
0.00%
More statistics
Low
31.49
High
31.49
Beta
0.74
Inst. own
90.00%
Dividend
0.00
Earnings
Aug 5, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CPRX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

20.00 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 13.3×
FY 2016: -4.8×FY 2017: -18.6×FY 2018: -5.8×FY 2019: 12.1×FY 2020: 4.6×FY 2021: 17.8×FY 2022: 23.3×FY 2023: 25.1×FY 2024: 15.1×FY 2025: 13.3×
FY 2016 5y median 17.8× FY 2025
P/S 4.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 394×FY 2019: 3.8×FY 2020: 2.9×FY 2021: 5.0×FY 2022: 9.0×FY 2023: 4.5×FY 2024: 5.0×FY 2025: 4.8×
FY 2016 5y median 5.0× FY 2025
P/B 3.0×
FY 2016: 2.2×FY 2017: 4.1×FY 2018: 3.9×FY 2019: 4.4×FY 2020: 2.0×FY 2021: 3.4×FY 2022: 6.4×FY 2023: 4.6×FY 2024: 3.4×FY 2025: 3.0×
FY 2016 5y median 3.4× FY 2025
P/FCF 13.7×
FY 2016: -4.8×FY 2017: -24.4×FY 2018: -7.6×FY 2019: 11.2×FY 2020: 7.7×FY 2021: 11.8×FY 2022: 16.6×FY 2023: 28.9×FY 2024: 10.3×FY 2025: 13.7×
FY 2016 5y median 13.7× FY 2025
EV/EBITDA 6.7×
FY 2016: -4.1×FY 2017: -15.0×FY 2018: -5.1×FY 2019: 9.3×FY 2020: 5.2×FY 2021: 10.1×FY 2022: 15.4×FY 2023: 13.0×FY 2024: 7.7×FY 2025: 6.7×
FY 2016 5y median 10.1× FY 2025
EV/Sales 3.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 361×FY 2019: 2.9×FY 2020: 1.8×FY 2021: 3.8×FY 2022: 7.6×FY 2023: 4.1×FY 2024: 4.0×FY 2025: 3.6×
FY 2016 5y median 4.0× FY 2025
FCF Yield 7.3%
FY 2016: -20.8%FY 2017: -4.1%FY 2018: -13.1%FY 2019: 9.0%FY 2020: 13.0%FY 2021: 8.5%FY 2022: 6.0%FY 2023: 3.5%FY 2024: 9.7%FY 2025: 7.3%
FY 2016 5y median 7.3% FY 2025

Profitability

Gross Margin 85.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -3883.8%FY 2019: 85.6%FY 2020: 85.7%FY 2021: 84.5%FY 2022: 83.9%FY 2023: 86.9%FY 2024: 86.0%FY 2025: 85.2%
FY 2016 5y median 85.2% FY 2025
Operating Margin 43.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -7059.0%FY 2019: 31.1%FY 2020: 34.7%FY 2021: 37.2%FY 2022: 47.5%FY 2023: 21.8%FY 2024: 39.7%FY 2025: 43.8%
FY 2016 5y median 39.7% FY 2025
Net Margin 36.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -6800.7%FY 2019: 31.2%FY 2020: 63.0%FY 2021: 28.0%FY 2022: 38.8%FY 2023: 17.9%FY 2024: 33.3%FY 2025: 36.4%
FY 2016 5y median 33.3% FY 2025
ROE 22.5%
FY 2016: -46.0%FY 2017: -22.7%FY 2018: -67.0%FY 2019: 36.4%FY 2020: 44.2%FY 2021: 19.1%FY 2022: 27.7%FY 2023: 18.4%FY 2024: 22.5%FY 2025: 22.5%
FY 2016 5y median 22.5% FY 2025
ROIC 20.3%
FY 2016: -48.7%FY 2017: -23.0%FY 2018: -69.3%FY 2019: 34.3%FY 2020: 24.3%FY 2021: 18.6%FY 2022: 25.4%FY 2023: 16.6%FY 2024: 20.2%FY 2025: 20.3%
FY 2016 5y median 20.2% FY 2025
ROA 19.4%
FY 2016: -43.3%FY 2017: -21.6%FY 2018: -56.3%FY 2019: 28.4%FY 2020: 39.0%FY 2021: 16.6%FY 2022: 22.1%FY 2023: 15.2%FY 2024: 19.2%FY 2025: 19.4%
FY 2016 5y median 19.2% FY 2025

Growth (YoY)

Revenue 19.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 20361.2%FY 2020: 16.4%FY 2021: 18.3%FY 2022: 52.1%FY 2023: 85.9%FY 2024: 23.5%FY 2025: 19.8%
FY 2016 FY 2025
Operating Income 32.1%
FY 2016: 5.5%FY 2017: 3.1%FY 2018: -88.9%FY 2019: 190.2%FY 2020: 29.8%FY 2021: 26.8%FY 2022: 94.4%FY 2023: -14.8%FY 2024: 124.8%FY 2025: 32.1%
FY 2016 FY 2025
EPS (diluted) 28.2%
FY 2016: 12.0%FY 2017: 4.5%FY 2018: -57.1%FY 2019: 190.9%FY 2020: 136.7%FY 2021: -47.9%FY 2022: 102.7%FY 2023: -16.0%FY 2024: 107.9%FY 2025: 28.2%
FY 2016 FY 2025
Free Cash Flow -12.8%
FY 2016: -0.1%FY 2017: 23.9%FY 2018: -87.7%FY 2019: 234.1%FY 2020: 30.2%FY 2021: 31.8%FY 2022: 95.5%FY 2023: -46.7%FY 2024: 286.8%FY 2025: -12.8%
FY 2016 FY 2025

Financial Health

Current Ratio 6.1×
FY 2016: 19.8×FY 2017: 20.0×FY 2018: 5.8×FY 2019: 4.6×FY 2020: 7.0×FY 2021: 7.8×FY 2022: 5.6×FY 2023: 2.9×FY 2024: 5.2×FY 2025: 6.1×
FY 2016 5y median 5.6× FY 2025
Quick Ratio 5.8×
FY 2016: 19.8×FY 2017: 20.0×FY 2018: 5.8×FY 2019: 4.5×FY 2020: 6.8×FY 2021: 7.5×FY 2022: 5.5×FY 2023: 2.7×FY 2024: 5.0×FY 2025: 5.8×
FY 2016 5y median 5.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -2.2×
FY 2016: 0.8×FY 2017: 3.1×FY 2018: 0.5×FY 2019: -2.8×FY 2020: -3.1×FY 2021: -3.2×FY 2022: -2.8×FY 2023: -1.1×FY 2024: -2.0×FY 2025: -2.2×
FY 2016 5y median -2.2× FY 2025
Interest Coverage 0.0×
FY 2016: -59.9×FY 2017: -41.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31